Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by EasyRider44on Jun 06, 2018 7:32pm

103 Views

Post# 28136232

RE:RE:THE DAY AFTER CANOPY'S BOUGHT DEAL IT SPIKED UP 22.9%

Accurate. Constellation caused the buying. Not the financing.

BuddingInvestor wrote:

Whatshisface wrote:

Shares of Canopy Growth rose as high as $15.72 in Toronto in morning trading on Monday, up 22.9 per cent from $12.79 at close on Friday. Shares closed at $15.22, up 19 per cent and marking its highest close ever.

Under the deal, Constellation will buy a 9.9 per cent stake or nearly a 18.9 million shares in Canopy for $12.9783 per share. It will also acquire an equal number of common share purchase warrants for Canopy.

And here we sit with a similar deal, only 8 months later and NO WARRANTS!

*** of important note for the tinfoil hats ***

APH has the EXACT same closing share price that WEED had for their BD

The same amount of shares were offered in the DEAL

Do WE know for a fact who will buy these shares from CLARUS???

DIAGEO? MOLSON? LOBLAWS?

We have a good thing growing!

It was constellation being involved that made it spike not the bought deal